Cargando…
Tenofovir and its potential in the treatment of hepatitis B virus
Recent literature is reviewed about treatment of chronic hepatitis B virus (CHB), focusing on tenofovir disoproxil fumarate (TDF; Viread(®)), among the nucleotide and nucleoside analogs. TDF pharmacokinetics and pharmacodynamics, activity in respect of hepatitis B virus (HBV) multi-drug-resistant mu...
Autores principales: | Reynaud, Laura, Carleo, Maria Aurora, Talamo, Maria, Borgia, Guglielmo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697525/ https://www.ncbi.nlm.nih.gov/pubmed/19436619 |
Ejemplares similares
-
Vertical transmission of hepatitis B virus: challenges and solutions
por: Gentile, Ivan, et al.
Publicado: (2014) -
Tenofovir alafenamide in the treatment of chronic hepatitis B virus
infection: rationale and clinical trial evidence
por: Byrne, Ruth, et al.
Publicado: (2018) -
An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia
por: Charlton, Michael R., et al.
Publicado: (2020) -
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
por: Inada, Kento, et al.
Publicado: (2021) -
Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review
por: Gentile, Ivan, et al.
Publicado: (2010)